Latest Knowledge On Plasma P-Tau In Alzheimers Disease

Latest knowledge on plasma p-tau in Alzheimer’s disease

Investigating novel plasma-based P-tau biomarkers

Upcoming plasma biomarkers for Alzheimer’s disease: Aβ, p-tau and GFAP

Plasma tau levels and Alzheimer’s disease: what’s the relationship?

Plasma p-tau181 to identify Alzheimer’s disease-related co-pathology in DLB

The value of plasma p-tau181 as a screening and diagnostic tool for Alzheimer’s disease

Markers of of tau pathology in Alzheimer’s disease

Beyond Aβ and p-Tau: novel biomarkers under investigation for Alzheimer’s disease

The accuracy of plasma biomarkers for Alzheimer’s disease outside of a controlled setting

Tau fragments as novel disease biomarkers: a pilot study for a plasma protein signature for AD

Using phosphorylated tau as a diagnostic tool for Alzheimer's disease

Head-to-head comparison of p-tau species for Alzheimer’s disease detection in a real-world cohort

Using plasma biomarkers in the diagnosis of Alzheimer’s disease

The potential of plasma biomarkers in dementia

Plasma p-tau as a biomarker for cerebral amyloid angiopathy diagnosis

Blood-based biomarkers for treatment monitoring in Alzheimer’s disease

Potential markers for alzheimer’s disease: Plasma p-tau181/Aβ1-42

Medical Dialogues

Comparing the performance of novel biomarkers across the spectrum of Alzheimer’s disease

The ability of plasma P-tau231 to detect preclinical Alzheimer’s disease

Blood p-tau in symptomatic and non-symptomatic AD patients